Investing Profile

Rob Hopfner

InvestorVC
Managing Partner at Pivotal Life Sciences
pivotalbiovp.com/team-members...San Francisco, California
Photo of Rob Hopfner, Managing Partner at Pivotal Life Sciences
Your Intro Paths to Rob Hopfner

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Rob is a member of
Stromedix Inc. Network
267 CONNECTIONS
The University of Chicago Booth School of Business Network
213 CONNECTIONS

Find Rob Hopfner on

cb
Current Investing Position
Pivotal Life Sciences Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
14

Rob Hopfner is on these Sector & Stage Rankings

Rob Hopfner's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Evommune
Series COct 2024$120M
Series BApr 2023$50M
Series ASep 2021$83M
SeedNov 2020$13M
$260M
Co-investors: Ash Khanna (SV Health Investors), Mark Chin (Jmi Equity), Derek DiRocco (RA Capital Management)
Oculis
Post Ipo EquityMar 2023$91M
Series CMay 2021$57M
Series BJan 2018$21M
$190M
Co-investors: Peter Bisgaard (Nan Fung Life Sciences), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Plexium
Series BFeb 2022$100M
Series AJan 2021$35M
$170M
Co-investors: Josh Wolfe (Lux Research), Adam Goulburn (6 Dimensions Capital), Tim Kutzkey (The Column Group), Kiersten Stead (DCVC Bio)
Rallybio
Series BApr 2020$150M
$180M
Co-investors: Tim Shannon (Canaan Partners)
Inozyme
Series AApr 2019$67M
$67M
Co-investors: Sarah Bhagat (Sofinnova Investments)
Civitas Therapeutics
Series CAug 2014$55M
Series BSep 2013$38M
$110M
Co-investors: Tim Shannon (Canaan Partners), Rajeev Shah (RA Capital Management)
Hyperion Therapeutics
Series CJun 2009$60M
$100M
Co-investors: Jake Nunn (New Enterprise Associates (NEA)), James Healy (Financial Services, Financial Technology, and Business Services)

Rob Hopfner's Experience

Board PTC Therapeutics, Inc.Present
Principal Bay City Capital LLCPresent
Board Stromedix Inc.Present
Board Dermira, Inc.Present
Board Mallinckrodt PharmaceuticalsPresent
Board OculisPresent
Board Inozyme PharmaPresent
Board EvommunePresent
Board PlexiumPresent
Executive Committee Pivotal Life SciencesPresent
Managing Director and Partner Bay City Capital LLCPresent
Managing Partner Pivotal Life SciencesPresent

Rob Hopfner's Education

The University of Chicago Booth School of Business MBA Finance, Strategy, Entrepreneurship
University of Saskatchewan Bachelor of Science (B.Sc.) Pharmacy
University of Saskatchewan Doctor of Philosophy (Ph.D.) Pharmacology

Investors who invest with Rob Hopfner

Sign in with Google →

Scouts & Angels Affiliated With Rob Hopfner

Sign in with Google →